Cargando…
Management of COVID-19 myopericarditis with reversal of cardiac dysfunction after blunting of cytokine storm: a case report
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a syndrome that has been associated with multiple cardiac complications including myopericarditis. The pathophysiology and treatment for myopericarditis in the setting of COVID-19 infection is still under investigation. CASE SUMMARY: We present a ca...
Autores principales: | Li, Angela, Garcia-Bengochea, Youssef, Stechel, Richard, Azari, Bani M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454501/ https://www.ncbi.nlm.nih.gov/pubmed/33089055 http://dx.doi.org/10.1093/ehjcr/ytaa224 |
Ejemplares similares
-
FRI497 Thyroid Storm And Recurrent Myopericarditis
por: Gomez D' Aza, Danelly J, et al.
Publicado: (2023) -
COVID-19 MYOPERICARDITIS- NEW STORMS, NEW NORMS?
por: Badejoko, Solomon O., et al.
Publicado: (2022) -
Isolated cardiac hydatid cyst presented as myopericarditis: A case report
por: Vakilian, Farveh, et al.
Publicado: (2020) -
COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm
por: Bradshaw, Patrick C., et al.
Publicado: (2020) -
Cytokine Storm
por: Fajgenbaum, David C., et al.
Publicado: (2020)